Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer

SIMPLE SUMMARY: The immune checkpoint blockade (ICB), and concretely the blockade of the PD1/PDL1 axis, has opened up a new standard of treatment for non-small cell lung cancer (NSCLC). However, despite substantial advances in clinical care, many patients still remain refractory to these therapies....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Zhang, Feiyu, Ferrero, Macarena, Dong, Ning, D’Auria, Giuseppe, Reyes-Prieto, Mariana, Herreros-Pomares, Alejandro, Calabuig-Fariñas, Silvia, Duréndez, Elena, Aparisi, Francisco, Blasco, Ana, García, Clara, Camps, Carlos, Jantus-Lewintre, Eloisa, Sirera, Rafael
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8196639/
https://ncbi.nlm.nih.gov/pubmed/34063829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13112514
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars